B-type natriuretic peptide (BNP) is used widely to exclude heart failure (HF) in patients with
dyspnea. However, most studies of BNP have focused on diagnosing HF with reduced …

Objectives: This study sought to determine the prognostic value of B-type natriuretic peptide
(BNP) in patients with heart failure with preserved ejection fraction (HFPEF), in comparison …

B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure Tamara B.
Horwich, Michele A. Hamilton, Gregg C. Fonarow Although recent studies show that obesity …

Background A substantial proportion of patients with heart failure (HF) with preserved
ejection fraction (HFpEF) present with normal natriuretic peptide (NP) levels. The …

Objectives: This study was designed to characterize the importance of echocardiographic
indexes, including newer indexes of diastolic function, as determinants of plasma B-type …

B-Type natriuretic peptide (BNP) is elevated in states of increased ventricular wall stress.
BNP is most commonly used to rule out congestive heart failure (CHF) in dyspneic patients …

Objectives: We explored the stimulus for B-type natriuretic peptide (BNP) secretion in the
clinical setting of heart failure (HF). Background: Increasingly, plasma BNP levels are being …

Background: Circulating B-type natriuretic peptide (BNP) concentrations strongly predict
mortality in patients with heart failure (HF). Both cardiac and extracardiac stimuli influence …

Cardiac secretion of B-type natriuretic peptide (BNP) increases with the progression of heart
failure (HF), and plasma measurement of BNP has emerged recently as a useful, cost …

Elevated plasma brain natriuretic (BNP) concentrations correlate with increased cardiac
filling pressures. Therefore, increased BNP has been proposed as a marker for …